We are live on
!
Find out more
Legend Biotech
LEGN
LEGN
210 hedge funds and large institutions have $3.23B invested in Legend Biotech in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 94 increasing their positions, 52 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
81% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 52
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
11% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 35
1.89% more ownership
Funds ownership: 25.04% → 26.94% (+1.9%)
1% more funds holding
Funds holding: 207 → 210 (+3)
27% less capital invested
Capital invested by funds: $4.44B → $3.23B (-$1.21B)
43% less call options, than puts
Call options by funds: $8.76M | Put options by funds: $15.3M
Holders
210
Holders Change
+3
Holders Change %
+1.45%
% of All Funds
2.77%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
39
Increased
94
Reduced
52
Closed
35
Calls
$8.76M
Puts
$15.3M
Net Calls
-$6.57M
Net Calls Change
+$5.16M
Top Buyers
| 1 |
SCM
Suvretta Capital Management
New York
|
+$145M |
| 2 |
Goldman Sachs
New York
|
+$84.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$65.8M |
| 4 |
DM
Deerfield Management
New York
|
+$64.3M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$59.5M |
